F756: Drug Regimen Review, Report Irregular, Act On
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
The document is ready to print
Click below to print the document in a new window. When finished, you can return to this tab to continue.
Print PDF
[customised-link]
Clearpol's Opinion of this Guidance as of 11/28/17
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.
Clearpol's AI Summary
This letter from CMS outlines the requirements for drug regimen reviews in nursing homes and other healthcare facilities. The reviews must be conducted at least once a month by a licensed pharmacist, and must include a review of the resident's medical chart. The pharmacist must report any irregularities to the attending physician, medical director, and director of nursing, and these reports must be acted upon. The facility must also develop and maintain policies and procedures for the monthly drug regimen review. The intent of this requirement is to maintain the resident's highest practicable level of physical, mental, and psychosocial well-being, and prevent or minimize adverse consequences related to medication therapy. Nursing homes and other healthcare facilities must comply with this requirement in order to ensure the safety and well-being of their residents.
Summaries are generataed using AI. Check important information.